In CKD, decreased kidney function and reduced responsiveness to the endocrine regulators result in hyperphosphatemia, that is accompanied by compensatory increases in serum levels of FGF23 and PTH and decreases in vitamin D [5, 29]. Here, FGF23 is linked to hyperphosphatemia.